Literature DB >> 25808040

Ling et al.'s 'Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder'.

Frances R Levin1, John J Mariani, Adam Bisaga, Edward V Nunes.   

Abstract

Entities:  

Keywords:  ADHD; cocaine dependence; methamphetamine use disorder; methylphenidate sustained-release; stimulant disorders; treatment

Mesh：

Substances：

Year:  2015        PMID： 25808040      PMCID： PMC4507796          DOI： 10.1111/add.12885

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  10 in total

1.  A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence.

Authors:  Jari Tiihonen; Kimmo Kuoppasalmi; Jaana Föhr; Pekka Tuomola; Outi Kuikanmäki; Helena Vorma; Petteri Sokero; Jari Haukka; Esa Meririnne
Journal:  Am J Psychiatry       Date:  2007-01       Impact factor: 18.112

2.  Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial.

Authors:  J Grabowski; H Rhoades; J Schmitz; A Stotts; L A Daruzska; D Creson; F G Moeller
Journal:  J Clin Psychopharmacol       Date:  2001-10       Impact factor: 3.153

3.  Baseline matters: the importance of covariation for baseline severity in the analysis of clinical trials.

Authors:  Edward V Nunes; Martina Pavlicova; Mei-Chen Hu; Aimee N Campbell; Gloria Miele; Denise Hien; Donald F Klein
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09       Impact factor: 3.829

Review 4.  Efficacy of psychostimulant drugs for cocaine dependence.

Authors:  Xavier Castells; Miguel Casas; Clara Pérez-Mañá; Carlos Roncero; Xavier Vidal; Dolors Capellà
Journal:  Cochrane Database Syst Rev       Date:  2010-02-17

5.  Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.

Authors:  Maija Konstenius; Nitya Jayaram-Lindström; Olof Beck; Johan Franck
Journal:  Drug Alcohol Depend       Date:  2009-12-16       Impact factor: 4.492

Review 6.  OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.

Authors:  J Antoni Ramos-Quiroga; Margarida Corominas; Xavier Castells; Rosa Bosch; Miguel Casas
Journal:  Expert Rev Neurother       Date:  2009-08       Impact factor: 4.618

7.  Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.

Authors:  Walter Ling; Linda Chang; Maureen Hillhouse; Alfonso Ang; Joan Striebel; Jessica Jenkins; Jasmin Hernandez; Mary Olaer; Larissa Mooney; Susan Reed; Erin Fukaya; Shannon Kogachi; Daniel Alicata; Nataliya Holmes; Asher Esagoff
Journal:  Addiction       Date:  2014-07-08       Impact factor: 6.526

8.  Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.

Authors:  Theresa M Winhusen; Eugene C Somoza; Gregory S Brigham; David S Liu; Carla A Green; Lirio S Covey; Ivana T Croghan; Lenard A Adler; Roger D Weiss; Jeffrey D Leimberger; Daniel F Lewis; Emily M Dorer
Journal:  J Clin Psychiatry       Date:  2010-05-18       Impact factor: 4.384

9.  Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial.

Authors:  John J Mariani; Martina Pavlicova; Adam Bisaga; Edward V Nunes; Daniel J Brooks; Frances R Levin
Journal:  Biol Psychiatry       Date:  2012-07-12       Impact factor: 13.382

10.  Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial.

Authors:  Maija Konstenius; Nitya Jayaram-Lindström; Joar Guterstam; Olof Beck; Björn Philips; Johan Franck
Journal:  Addiction       Date:  2013-12-01       Impact factor: 6.526
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.